TY - PAT
T1 - Molecular biomarker set for early detection of ovarian cancer
AU - Bajic, Vladimir B.
AU - Kaur, Mandeep
N1 - KAUST Repository Item: Exported on 2019-02-13
PY - 2015/6/16
Y1 - 2015/6/16
N2 - Embodiments of the present invention concern methods and compositions related to detection of ovarian cancer, including detection of the stage of ovarian cancer, in some cases. In particular, the invention encompasses use of expression of TFAP2A and in some embodiments CA125 and/or E2F5 to identify ovarian cancer, including detecting mRNA and/or protein levels of the respective gene products. Kits for detection of ovarian cancer are also described.
AB - Embodiments of the present invention concern methods and compositions related to detection of ovarian cancer, including detection of the stage of ovarian cancer, in some cases. In particular, the invention encompasses use of expression of TFAP2A and in some embodiments CA125 and/or E2F5 to identify ovarian cancer, including detecting mRNA and/or protein levels of the respective gene products. Kits for detection of ovarian cancer are also described.
UR - http://hdl.handle.net/10754/594750
UR - http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=9057107
UR - http://assignment.uspto.gov/#/search?adv=patNum:9057107
UR - http://www.google.com/patents/US9057107
UR - http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=9057107B2&KC=B2&FT=D
M3 - Patent
M1 - US 9057107 B2
ER -
